November 26, 2012
Healthcare professionals are raising concerns about the Japan Pharmaceutical Manufacturers Association’s (JPMA) transparency guidelines (GLs), under which JPMA members are expected to disclose R&D costs paid to medical institutions and seminar fees for doctors from FY2013. At a meeting of...read more